FMP

FMP

Enter

HJLI - enVVeno Medical...

photo-url-https://financialmodelingprep.com/image-stock/HJLI.jpg

enVVeno Medical Corporation

HJLI

NASDAQ

Inactive Equity

Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. The company is headquartered in Irvine, California and currently employs 9 full-time employees. The firm is developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD). The firm is in the process of developing bioprosthetic implantable devices for cardiovascular disease. The Company’s Bioprosthetic Heart Valve (BHV), is a bioprosthetic, pig heart valve designed to function like a native heart valve, and designed to provide a patient greater functional performance than available devices. The Company’s product Venous Valve is a bioprosthetic, pig venous valve for patients with lower limb chronic venous insufficiency (CVI), which occurs because of damage to the valves of the veins in the legs after patients develop blood clots in the deep venous system.

10.38 USD

-0.21000004 (-2.02%)

About

ceo

Mr. Robert A. Berman

sector

Healthcare

industry

Medical - Devices

exchange

NASDAQ

Description

Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. The company is headquartered in Irvine, California and currently employs 9 full-time employees. The firm is developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD). The firm is in the process of developing bioprosthetic implantable devices for cardiovascular disease. The Company’s Bioprosthetic Heart ...

CIK

0001661053

ISIN

US41015N1063

CUSIP

41015N106

Address

70 Doppler

Phone

19492612900

Country

US

Employee

19

IPO Date

May 31, 2018

HJLI Financial Summary

CIK

0001661053

Exchange

NASDAQ

Industry

Medical - Devices

Sector

Healthcare

CUSIP

41015N106

ISIN

US41015N1063

Country

US

Price

10.38

Beta

1.54

Volume Avg.

777.48k

Market Cap

98.32M

Shares

-

52-Week

10.26-10.74

DCF

11.12

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

0

P/B

-

Website

http://www.hancockjaffe.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest HJLI News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep